刘磊, 周力, 陈晖. 对比剂致急性肾损伤的发病机制研究进展[J]. 心脏杂志, 2019, 31(6): 723-726. DOI: 10.12125/j.chj.201904027
    引用本文: 刘磊, 周力, 陈晖. 对比剂致急性肾损伤的发病机制研究进展[J]. 心脏杂志, 2019, 31(6): 723-726. DOI: 10.12125/j.chj.201904027
    Lei LIU, Li ZHOU, Hui CHEN. Research progress in pathogenesis of contrast induced acute kidney injury[J]. Chinese Heart Journal, 2019, 31(6): 723-726. DOI: 10.12125/j.chj.201904027
    Citation: Lei LIU, Li ZHOU, Hui CHEN. Research progress in pathogenesis of contrast induced acute kidney injury[J]. Chinese Heart Journal, 2019, 31(6): 723-726. DOI: 10.12125/j.chj.201904027

    对比剂致急性肾损伤的发病机制研究进展

    Research progress in pathogenesis of contrast induced acute kidney injury

    • 摘要: 随着冠脉造影技术的广泛开展,如何有效降低术后对比剂致急性肾损伤(CI-AKI)的发生率一直是心血管领域研究的热点。但其发病机制较为复杂,且尚未完全明确,既往研究表明多种因素引起的肾脏血流动力学改变、对比剂本身对肾小管细胞及内皮细胞的毒性作用、氧化应激反应等机制参与CI-AKI的发病过程。本文将对发病机制目前的研究现状进行综述。

       

      Abstract: With the extensive development of coronary angiography, how to effectively reduce the incidence of contrast induced acute kidney injury has been the focus of cardiovascular research. However, the pathogenesis of contrast induced acute kidney injury is complex and not clear yet. Previous studies have shown that renal hemodynamic changes, toxicity of the contrast to renal tubular cells and endothelial cells, and the oxidative stress caused by many factors are involved. This article will review the current research status of the pathogenesis of contrast induced acute kidney injury.

       

    /

    返回文章
    返回